Pseudobulbar

Pseudobulbar refers to conditions involving the bilateral corticobulbar pathways that control the muscles of the face, tongue, throat, and related structures. The term is most often encountered in two related but distinct clinical contexts: pseudobulbar palsy and pseudobulbar affect. Pseudobulbar palsy describes motor impairment due to bilateral upper motor neuron lesions affecting bulbar muscles, whereas pseudobulbar affect describes a symptom cluster of emotional lability that can occur with various neurologic diseases.

Pseudobulbar palsy results from damage to the corticobulbar tracts in the brain or brainstem. It presents with spastic dysarthria (slurred, slow speech), dysphagia (swallowing difficulties), facial weakness or asymmetry, a stiff or clenched jaw, excessive gag reflex, and increased muscle tone in bulbar muscles. Reflexes such as the jaw jerk may be exaggerated. Sensory function is typically preserved, but voluntary control over bulbar muscles is impaired. This condition often reflects an underlying brain injury or degenerative disease.

Pseudobulbar affect is characterized by sudden, uncontrollable episodes of laughing or crying that are incongruent with the person's mood or social context. It occurs in various neurologic conditions, including amyotrophic lateral sclerosis, multiple sclerosis, stroke, traumatic brain injury, and hydrocephalus. The episodes are not purposeful and can be disabling, impacting social functioning and quality of life. Diagnosis is clinical, supported by history and, when needed, scales such as the Center for Neurologic Study-Lability Scale, with imaging to assess underlying pathology.

Treatment targets the underlying disease and specific symptoms. Pseudobulbar affect can respond to medications such as dextromethorphan–quinidine and, in some cases, antidepressants. Pseudobulbar palsy management emphasizes supportive therapies, including speech and swallowing therapy, physical therapy, and strategies to manage spasticity and aspiration risk. Prognosis depends on the underlying condition and its progression.